Cisplatin in combination with continuous VP16 infusion as second line chemotherapy in ovarian carcinoma. A pilot study
Menczer, J.; Ben-Baruch, G.; Rizel, S.; Brenner, H.
European Journal of Gynaecological Oncology 13(4): 316-318
1992
ISSN/ISBN: 0392-2936 PMID: 1516581 Document Number: 393062
Effective second line chemotherapy schedules for recurrent ovarian carcinoma are not available. The combination of cisplatin and VP-16 given as a single dose in such patients gave inconsistent results. Since VP-16 is a dose-schedule dependent drug it was given in this pilot study as a continuous 72 hour infusion at a dose of 100 mg/m2/day. No objective response was observed among 7 patients with refractory or recurrent ovarian carcinoma who received a median of 3 treatment courses.
Document emailed within 1 workday
Related Documents
Seike, M.; Andoh, M.; Hasegawa, K.; Sakonji, M.; Tsuboi, E. 1998: Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(10): 1539-1542Sasaki, K.; Hirata, K.; Denno, R.; Oikawa, I.; Mukaiya, M.; Hiraike, N.; Yagihashi, A.; Takasaka, H.; Katsuramaki, T.; Yamashiro, K.; Yamamitsu, S.; Shirasaka, T. 1997: Combination chemotherapy of continuous infusion 5-fluorouracil and daily low-dose cisplatin in advanced gastrointestinal and lung adenocarcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(8): 959-964
Kamata, T.; Hayashi, Y.; Minatoya, G.; Michiwa, Y.; Onishi, I.; Takeda, T.; Koyasaki, N.; Kanno, M. 2001: A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1419-1422
Takahashi, T.; Saikawa, Y.; Yoshida, M.; Kitagawa, Y.; Otani, Y.; Kubota, T.; Kumai, K.; Kitajima, M. 2006: A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer Anticancer Research 26(2b): 1631-1635
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Makhnova, E.V. 2003: Combination chemotherapy with Hemzar (gemcitabine) and cisplatin for relapsing and cisplatin-resistant ovarian cancer Voprosy Onkologii 49(1): 60-65
Takezako, Y.; Okusaka, T.; Ueno, H.; Ikeda, M.; Morizane, C.; Najima, M. 2008: Phase Ii study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC) Hepato-Gastroenterology 55(85): 1380-1384
Tsukamoto, T.; Kanazawa, A.; Shimizu, S.; Murata, A.; Sakae, M.; Kurihara, S.; Tashima, T.; Deguchi, S.; Nakai, T.; Kawasaki, Y.; Kioka, K. 2015: Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1878-1880
Tanaka, A.; Aragane, N.; Komiya, K.; Kawaura, F.; Fukuno, Y.; Hayashi, S. 2008: A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 49-53
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Tabbara, I.A.; Quesenberry, P.J.; Hahn, S.S.; Stewart, F.M. 1989: Treatment of small cell carcinoma with weekly combination chemotherapy. A pilot study Anticancer Research 9(1): 189-192
Scotto, V.; Sbiroli, C. 1991: Weekly cis-platinum as third line chemotherapy in advanced ovarian carcinoma. Phase Ii study European Journal of Gynaecological Oncology 12(1): 51-53
Itano, S.; Hirai, K.; Kajiwara, M.; Ijuin, H.; Yoshiyama, Y.; Yoshida, T.; Sakata, K.; Ono, N.; Noguchi, H.; Sakai, T. 1994: A study of the drug distribution on intra-hepatic arterial infusion chemotherapy; how much difference between continuous infusion and rapid infusion? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2136-2139
Topuz, E.; Saip, P.; Aydmer, A.; Salihoğlu, Y.; Berkman, S.; Bengisu, E. 1998: Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer European Journal of Gynaecological Oncology 19(3): 265-270
West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Sukhaboon, J.; Porapakkhan, P.; Penpattanagul, S. 2009: Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study Journal of the Medical Association of Thailand 92(8): 1072-1076
Skarlos, D.V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G.P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. 1997: Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study Seminars in Oncology 24(5 Suppl 15: S15
Kelsen, D.P.; Bains, M.; Chapman, R.; Golbey, R. 1981: Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma Cancer Treatment Reports 65(9-10): 781-785
Li, J.-h.; Li, B.; Jiang, H.-r.; Zhong, M.-z. 2011: Weekly regimen of paclitaxel liposome combined with cisplatin and 5-fluorouracil continuous infusion in the treatment of advanced gastric carcinoma Zhonghua Zhong Liu Za Zhi 33(3): 229-231
Franchi, F.; Pastore, C.; Seminara, P. 2006: CMF with 5-FU in continuous infusion--a pilot study European Journal of Gynaecological Oncology 27(2): 204